Guide · Markets
13F Filings Explained: What Big Investors Must Disclose
A 13F is the quarterly SEC report in which managers with over $100 million list their US stock holdings, 45 days after quarter end. Berkshire's is due Nov 16, 2026.
On Monday, November 16, 2026, Berkshire Hathaway will publish a short document that dozens of journalists and fund managers have been waiting for since the summer: its Form 13F for the quarter that ended on September 30. It will show, line by line, which US-listed stocks the company owned on that date and how many shares of each. Berkshire's shares had just hit their 11th record close of the quarter, and investors wanted to know whether it kept selling Bank of America and kept buying Alphabet. The 13F answers questions like that, but only within strict limits that are worth knowing before you read one.
The rule comes from Section 13(f) of the Securities Exchange Act, added in 1975. Any institutional investment manager that exercises discretion over at least $100 million of so-called 13(f) securities must file a 13F with the SEC within 45 days of the end of each calendar quarter. That covers mutual fund companies, hedge funds, pension managers, banks, insurers and holding companies such as Berkshire. When the 45th day falls on a weekend, the deadline moves to the next business day, which is why the third-quarter deadline of Saturday, November 14 becomes Monday, November 16 this year. Filings appear free on the SEC's EDGAR database.
What the form shows is narrow. It lists long positions in 13(f) securities: US exchange-listed stocks, many ETFs, some convertible bonds and listed options, with the number of shares, the market value at quarter end and whether the manager has voting power. What it leaves out is often more important. Short positions are not reported, so a hedge fund that owns a stock and shorts its competitor shows only half its trade. Cash, Treasury bills, most bonds, private companies and shares listed only abroad are absent: Berkshire's Japanese trading-house stakes, worth tens of billions of dollars, never appear on its 13F. And the snapshot is 45 days old on arrival.
Managers can also ask the SEC for confidential treatment of a position they are still building, so that rivals cannot copy it before they finish. Berkshire has used this several times; its stake in insurer Chubb was kept out of its public 13Fs for the last two quarters of 2023 and revealed in May 2024. When a filing contains a new holding that suddenly appears at full size, a previous confidential request is often the reason. Larger stakes have their own faster rules: crossing 5% of a company triggers a Schedule 13D or 13G, and holders of more than 10% must report trades on Form 4 within two business days, which is why Berkshire's Bank of America sales were public in near real time in 2024 while it was above that threshold.
Reading a 13F well means comparing it with the previous one. Berkshire's second-quarter 13F, filed in August, showed its Alphabet stake up 45.2% and its Bank of America holding down 5.9%, to 483.4 million shares. That change, not the level, is what moves headlines and sometimes prices. Some investors go further and estimate the filing in advance: Berkshire's 10-Q, filed with its third-quarter results on November 7, showed a $372 million drop in the cost basis of its banks, insurance and finance holdings and a $2.3 billion rise in another category, which led Barron's to expect more Bank of America sales and more Alphabet purchases before the 13F confirmed either.
For a trader, the main use of 13Fs is context rather than signals. Copying a famous investor's portfolio means buying positions that may already have been sold, at prices that have already moved, without the hedges or cash that made them sensible. What the filings do well is show crowding: when many funds hold the same stock, a disappointment can trigger forced selling, and when a respected long-term holder exits a name over many quarters, as Berkshire has done with Bank of America since mid-2024, it tells you something about how one patient investor values it at current prices.